The Diagnostic Significance of Coapplying a Rabeprazole Test with the SF-36 for Gastroesophageal Reflux Disease

Table 7

Sensitivity and specificity of the rabeprazole test combined with SF-36 in diagnosing GERD when 𝑃=0.606.

Screening results	GERD		Non-GERD		Total
	Number of patients	95% CI (%)	Number of patients	95% CI (%)	Number of patients	95% CI (%)
+	67	94.4 (89.1–99.7); Sensitivity	4	21.1 (2.7–39.4); False positive	71	94.3 (88.9–99.7); Positive predictive value
−	4	5.6 (0.2–10.9); False negative	15	78.9 (60.5–97.2); Specificity	19	67.8 (60.6–97.2); Negative predictive value
Total	71	100	19	100	90	91.1 (85.2–96.9); Coincident rate